Sauder Schelkopf is investigating allegations that patients of Natera may have experienced excessive, unnecessary, and/or higher than promised charges related to the company’s genetic testing services. Natera describes itself as an “in cell-free DNA (cfDNA) testing with a focus on women’s health, oncology, and organ health.”
Related News:
Why Patients Are Getting Hit With Surprise Bills After Genetic Testing
Prenatal Testing Leads To Unexpected, Staggering Bills For Some Parents
Natera settles U.S. billing probe over prenatal gene tests for $11.4 mln
Experience Matters
Sauder Schelkopf has a nationally recognized class action and personal injury law firm.
- We filed the first class action lawsuit in the country against Allergan on behalf of women who had recalled breast implants and our firm was court appointed to serve on the steering committee.
- We represented women in a lawsuit against Ferring Pharmaceuticals, Inc. related to the manufacture and sale of its fertility drug, Bravelle. It was alleged that over an 18 month period Ferring knew or had reason to know that Bravelle was sub-potent and could not deliver on its promised benefits.
- We represented women who were implanted with Essure, a female birth control device. It is alleged that the devices migrated and fractured, punctured internal organs or caused other injuries.
- We represent patients of Pacific Fertility Center who allege their frozen eggs and embryos were impacted by a cryopreservation tank failure at PFC’s San Francisco clinic in early March 2018.
We Want to Hear from You
If you were billed an excessive, unnecessary, or higher than promised amount for testing by Natera, contact the lawyers at Sauder Schelkopf by filling out the form on this page.